世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
酸化ストレスアッセイ市場。世界の産業動向、シェア、サイズ、成長、機会、および2021-2026年の予測Oxidative Stress Assay Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 The global oxidative stress assay market reached a value of US$ 836 Million in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 9.7% during 2021-2026. Keeping in mind the ... もっと見る
サマリーThe global oxidative stress assay market reached a value of US$ 836 Million in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 9.7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.Oxidative stress is a health condition wherein excessive production of oxygen-derived free radicals within a cell or organism overwhelms the intrinsic antioxidant defenses. It causes oxidative damage to proteins, lipids and nucleic acids, which can further lead to the development of cancer, asthma, ischemia, diabetes, and cardiovascular and neurodegenerative diseases. It is assessed using a number of assays that help healthcare researchers gain a better understanding of the mechanisms and responses of the condition. Free radicals can be produced due to biological factors, unhealthy dietary habits and air pollution. This, in confluence with the rising number of individuals who smoke and consume alcohol, is escalating the risk of developing oxidative stress, which, in turn, is strengthening the market growth. Apart from this, the development of various pathologic conditions and acceleration of the aging process on account of oxidative stress is also bolstering the market growth. Furthermore, the growing biopharmaceutical industry, increasing investments in the research and development (R&D) activities and technological advancements, such as high-content screening for drug discovery, are acting as other major factors stimulating the market growth. Moreover, oxidative stress is also being considered as a major factor contributing to the severity of the coronavirus disease (COVID-19). It is also being evaluated as a probable cause of multi-organ failure among patients. The ongoing studies on the interrelation between the disease and oxidative stress are expected to positively influence the market growth. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global oxidative stress assay market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, technology, test type and end user. Breakup by Product: Reagents and Consumables Instruments Services Breakup by Technology: ELISA (Enzyme-Linked Immunosorbent Assay) Flow Cytometry Chromatography Microscopy High-Content Screening Label-Free Detection Others Breakup by Test Type: Indirect Assays Protein-Based Assays Lipid-Based Assays Nucleic Acid-Based Assays Antioxidant Capacity Assays Glutathione Assays Ascorbic Acid Assays Cell-Based Exogenous Antioxidant Assays Enzyme-Based Assays Reactive Oxygen Species-Based Assays Breakup by End User: Pharmaceutical Industry Research Institutes Others Breakup by Region: North America United States Canada Asia Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The report has also analysed the competitive landscape of the market with some of the key players being Abcam PLC, AMS Biotechnology (Europe) Ltd., Biovision Inc. (Boai NKY Medical Holdings Ltd.), Cell Biolabs Inc., Enzo Biochem Inc., ImmunoChemistry Technologies LLC, Merck KGaA, Oxford Biomedical Research, Promega Corporation, Qiagen N.V. and Thermo Fisher Scientific Inc. Key Questions Answered in This Report: How has the global oxidative stress assay market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global oxidative stress assay market? What are the key regional markets? What is the breakup of the market based on the product? What is the breakup of the market based on the technology? What is the breakup of the market based on the test type? What is the breakup of the market based on the end user? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global oxidative stress assay market and who are the key players? What is the degree of competition in the industry? 目次1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Oxidative Stress Assay Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product 6.1 Reagents and Consumables 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Instruments 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Services 6.3.1 Market Trends 6.3.2 Market Forecast 7 Market Breakup by Technology 7.1 ELISA (Enzyme-Linked Immunosorbent Assay) 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Flow Cytometry 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Chromatography 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Microscopy 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 High-Content Screening 7.5.1 Market Trends 7.5.2 Market Forecast 7.6 Label-Free Detection 7.6.1 Market Trends 7.6.2 Market Forecast 7.7 Others 7.7.1 Market Trends 7.7.2 Market Forecast 8 Market Breakup by Test Type 8.1 Indirect Assays 8.1.1 Market Trends 8.1.2 Major Types 8.1.2.1 Protein-Based Assays 8.1.2.2 Lipid-Based Assays 8.1.2.3 Nucleic Acid-Based Assays 8.1.3 Market Forecast 8.2 Antioxidant Capacity Assays 8.2.1 Market Trends 8.2.2 Major Types 8.2.2.1 Glutathione Assays 8.2.2.2 Ascorbic Acid Assays 8.2.2.3 Cell-Based Exogenous Antioxidant Assays 8.2.3 Market Forecast 8.3 Enzyme-Based Assays 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Reactive Oxygen Species-Based Assays 8.4.1 Market Trends 8.4.2 Market Forecast 9 Market Breakup by End User 9.1 Pharmaceutical Industry 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Research Institutes 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Others 9.3.1 Market Trends 9.3.2 Market Forecast 10 Market Breakup by Region 10.1 North America 10.1.1 United States 10.1.1.1 Market Trends 10.1.1.2 Market Forecast 10.1.2 Canada 10.1.2.1 Market Trends 10.1.2.2 Market Forecast 10.2 Asia Pacific 10.2.1 China 10.2.1.1 Market Trends 10.2.1.2 Market Forecast 10.2.2 Japan 10.2.2.1 Market Trends 10.2.2.2 Market Forecast 10.2.3 India 10.2.3.1 Market Trends 10.2.3.2 Market Forecast 10.2.4 South Korea 10.2.4.1 Market Trends 10.2.4.2 Market Forecast 10.2.5 Australia 10.2.5.1 Market Trends 10.2.5.2 Market Forecast 10.2.6 Indonesia 10.2.6.1 Market Trends 10.2.6.2 Market Forecast 10.2.7 Others 10.2.7.1 Market Trends 10.2.7.2 Market Forecast 10.3 Europe 10.3.1 Germany 10.3.1.1 Market Trends 10.3.1.2 Market Forecast 10.3.2 France 10.3.2.1 Market Trends 10.3.2.2 Market Forecast 10.3.3 United Kingdom 10.3.3.1 Market Trends 10.3.3.2 Market Forecast 10.3.4 Italy 10.3.4.1 Market Trends 10.3.4.2 Market Forecast 10.3.5 Spain 10.3.5.1 Market Trends 10.3.5.2 Market Forecast 10.3.6 Russia 10.3.6.1 Market Trends 10.3.6.2 Market Forecast 10.3.7 Others 10.3.7.1 Market Trends 10.3.7.2 Market Forecast 10.4 Latin America 10.4.1 Brazil 10.4.1.1 Market Trends 10.4.1.2 Market Forecast 10.4.2 Mexico 10.4.2.1 Market Trends 10.4.2.2 Market Forecast 10.4.3 Others 10.4.3.1 Market Trends 10.4.3.2 Market Forecast 10.5 Middle East and Africa 10.5.1 Market Trends 10.5.2 Market Breakup by Country 10.5.3 Market Forecast 11 SWOT Analysis 11.1 Overview 11.2 Strengths 11.3 Weaknesses 11.4 Opportunities 11.5 Threats 12 Value Chain Analysis 13 Porters Five Forces Analysis 13.1 Overview 13.2 Bargaining Power of Buyers 13.3 Bargaining Power of Suppliers 13.4 Degree of Competition 13.5 Threat of New Entrants 13.6 Threat of Substitutes 14 Price Analysis 15 Competitive Landscape 15.1 Market Structure 15.2 Key Players 15.3 Profiles of Key Players 15.3.1 Abcam PLC 15.3.1.1 Company Overview 15.3.1.2 Product Portfolio 15.3.1.3 Financials 15.3.1.4 SWOT Analysis 15.3.2 AMS Biotechnology (Europe) Ltd. 15.3.2.1 Company Overview 15.3.2.2 Product Portfolio 15.3.3 Biovision Inc. (Boai NKY Medical Holdings Ltd.) 15.3.3.1 Company Overview 15.3.3.2 Product Portfolio 15.3.4 Cell Biolabs Inc. 15.3.4.1 Company Overview 15.3.4.2 Product Portfolio 15.3.5 Enzo Biochem Inc. 15.3.5.1 Company Overview 15.3.5.2 Product Portfolio 15.3.5.3 Financials 15.3.5.4 SWOT Analysis 15.3.6 ImmunoChemistry Technologies LLC 15.3.6.1 Company Overview 15.3.6.2 Product Portfolio 15.3.7 Merck KGaA 15.3.7.1 Company Overview 15.3.7.2 Product Portfolio 15.3.7.3 Financials 15.3.7.4 SWOT Analysis 15.3.8 Oxford Biomedical Research 15.3.8.1 Company Overview 15.3.8.2 Product Portfolio 15.3.9 Promega Corporation 15.3.9.1 Company Overview 15.3.9.2 Product Portfolio 15.3.10 Qiagen N.V. 15.3.10.1 Company Overview 15.3.10.2 Product Portfolio 15.3.11 Thermo Fisher Scientific Inc. 15.3.11.1 Company Overview 15.3.11.2 Product Portfolio 15.3.11.3 Financials 15.3.11.4 SWOT Analysis
SummaryThe global oxidative stress assay market reached a value of US$ 836 Million in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 9.7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.Oxidative stress is a health condition wherein excessive production of oxygen-derived free radicals within a cell or organism overwhelms the intrinsic antioxidant defenses. It causes oxidative damage to proteins, lipids and nucleic acids, which can further lead to the development of cancer, asthma, ischemia, diabetes, and cardiovascular and neurodegenerative diseases. It is assessed using a number of assays that help healthcare researchers gain a better understanding of the mechanisms and responses of the condition. Free radicals can be produced due to biological factors, unhealthy dietary habits and air pollution. This, in confluence with the rising number of individuals who smoke and consume alcohol, is escalating the risk of developing oxidative stress, which, in turn, is strengthening the market growth. Apart from this, the development of various pathologic conditions and acceleration of the aging process on account of oxidative stress is also bolstering the market growth. Furthermore, the growing biopharmaceutical industry, increasing investments in the research and development (R&D) activities and technological advancements, such as high-content screening for drug discovery, are acting as other major factors stimulating the market growth. Moreover, oxidative stress is also being considered as a major factor contributing to the severity of the coronavirus disease (COVID-19). It is also being evaluated as a probable cause of multi-organ failure among patients. The ongoing studies on the interrelation between the disease and oxidative stress are expected to positively influence the market growth. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global oxidative stress assay market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, technology, test type and end user. Breakup by Product: Reagents and Consumables Instruments Services Breakup by Technology: ELISA (Enzyme-Linked Immunosorbent Assay) Flow Cytometry Chromatography Microscopy High-Content Screening Label-Free Detection Others Breakup by Test Type: Indirect Assays Protein-Based Assays Lipid-Based Assays Nucleic Acid-Based Assays Antioxidant Capacity Assays Glutathione Assays Ascorbic Acid Assays Cell-Based Exogenous Antioxidant Assays Enzyme-Based Assays Reactive Oxygen Species-Based Assays Breakup by End User: Pharmaceutical Industry Research Institutes Others Breakup by Region: North America United States Canada Asia Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The report has also analysed the competitive landscape of the market with some of the key players being Abcam PLC, AMS Biotechnology (Europe) Ltd., Biovision Inc. (Boai NKY Medical Holdings Ltd.), Cell Biolabs Inc., Enzo Biochem Inc., ImmunoChemistry Technologies LLC, Merck KGaA, Oxford Biomedical Research, Promega Corporation, Qiagen N.V. and Thermo Fisher Scientific Inc. Key Questions Answered in This Report: How has the global oxidative stress assay market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global oxidative stress assay market? What are the key regional markets? What is the breakup of the market based on the product? What is the breakup of the market based on the technology? What is the breakup of the market based on the test type? What is the breakup of the market based on the end user? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global oxidative stress assay market and who are the key players? What is the degree of competition in the industry? Table of Contents1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Oxidative Stress Assay Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product 6.1 Reagents and Consumables 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Instruments 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Services 6.3.1 Market Trends 6.3.2 Market Forecast 7 Market Breakup by Technology 7.1 ELISA (Enzyme-Linked Immunosorbent Assay) 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Flow Cytometry 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Chromatography 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Microscopy 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 High-Content Screening 7.5.1 Market Trends 7.5.2 Market Forecast 7.6 Label-Free Detection 7.6.1 Market Trends 7.6.2 Market Forecast 7.7 Others 7.7.1 Market Trends 7.7.2 Market Forecast 8 Market Breakup by Test Type 8.1 Indirect Assays 8.1.1 Market Trends 8.1.2 Major Types 8.1.2.1 Protein-Based Assays 8.1.2.2 Lipid-Based Assays 8.1.2.3 Nucleic Acid-Based Assays 8.1.3 Market Forecast 8.2 Antioxidant Capacity Assays 8.2.1 Market Trends 8.2.2 Major Types 8.2.2.1 Glutathione Assays 8.2.2.2 Ascorbic Acid Assays 8.2.2.3 Cell-Based Exogenous Antioxidant Assays 8.2.3 Market Forecast 8.3 Enzyme-Based Assays 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Reactive Oxygen Species-Based Assays 8.4.1 Market Trends 8.4.2 Market Forecast 9 Market Breakup by End User 9.1 Pharmaceutical Industry 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Research Institutes 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Others 9.3.1 Market Trends 9.3.2 Market Forecast 10 Market Breakup by Region 10.1 North America 10.1.1 United States 10.1.1.1 Market Trends 10.1.1.2 Market Forecast 10.1.2 Canada 10.1.2.1 Market Trends 10.1.2.2 Market Forecast 10.2 Asia Pacific 10.2.1 China 10.2.1.1 Market Trends 10.2.1.2 Market Forecast 10.2.2 Japan 10.2.2.1 Market Trends 10.2.2.2 Market Forecast 10.2.3 India 10.2.3.1 Market Trends 10.2.3.2 Market Forecast 10.2.4 South Korea 10.2.4.1 Market Trends 10.2.4.2 Market Forecast 10.2.5 Australia 10.2.5.1 Market Trends 10.2.5.2 Market Forecast 10.2.6 Indonesia 10.2.6.1 Market Trends 10.2.6.2 Market Forecast 10.2.7 Others 10.2.7.1 Market Trends 10.2.7.2 Market Forecast 10.3 Europe 10.3.1 Germany 10.3.1.1 Market Trends 10.3.1.2 Market Forecast 10.3.2 France 10.3.2.1 Market Trends 10.3.2.2 Market Forecast 10.3.3 United Kingdom 10.3.3.1 Market Trends 10.3.3.2 Market Forecast 10.3.4 Italy 10.3.4.1 Market Trends 10.3.4.2 Market Forecast 10.3.5 Spain 10.3.5.1 Market Trends 10.3.5.2 Market Forecast 10.3.6 Russia 10.3.6.1 Market Trends 10.3.6.2 Market Forecast 10.3.7 Others 10.3.7.1 Market Trends 10.3.7.2 Market Forecast 10.4 Latin America 10.4.1 Brazil 10.4.1.1 Market Trends 10.4.1.2 Market Forecast 10.4.2 Mexico 10.4.2.1 Market Trends 10.4.2.2 Market Forecast 10.4.3 Others 10.4.3.1 Market Trends 10.4.3.2 Market Forecast 10.5 Middle East and Africa 10.5.1 Market Trends 10.5.2 Market Breakup by Country 10.5.3 Market Forecast 11 SWOT Analysis 11.1 Overview 11.2 Strengths 11.3 Weaknesses 11.4 Opportunities 11.5 Threats 12 Value Chain Analysis 13 Porters Five Forces Analysis 13.1 Overview 13.2 Bargaining Power of Buyers 13.3 Bargaining Power of Suppliers 13.4 Degree of Competition 13.5 Threat of New Entrants 13.6 Threat of Substitutes 14 Price Analysis 15 Competitive Landscape 15.1 Market Structure 15.2 Key Players 15.3 Profiles of Key Players 15.3.1 Abcam PLC 15.3.1.1 Company Overview 15.3.1.2 Product Portfolio 15.3.1.3 Financials 15.3.1.4 SWOT Analysis 15.3.2 AMS Biotechnology (Europe) Ltd. 15.3.2.1 Company Overview 15.3.2.2 Product Portfolio 15.3.3 Biovision Inc. (Boai NKY Medical Holdings Ltd.) 15.3.3.1 Company Overview 15.3.3.2 Product Portfolio 15.3.4 Cell Biolabs Inc. 15.3.4.1 Company Overview 15.3.4.2 Product Portfolio 15.3.5 Enzo Biochem Inc. 15.3.5.1 Company Overview 15.3.5.2 Product Portfolio 15.3.5.3 Financials 15.3.5.4 SWOT Analysis 15.3.6 ImmunoChemistry Technologies LLC 15.3.6.1 Company Overview 15.3.6.2 Product Portfolio 15.3.7 Merck KGaA 15.3.7.1 Company Overview 15.3.7.2 Product Portfolio 15.3.7.3 Financials 15.3.7.4 SWOT Analysis 15.3.8 Oxford Biomedical Research 15.3.8.1 Company Overview 15.3.8.2 Product Portfolio 15.3.9 Promega Corporation 15.3.9.1 Company Overview 15.3.9.2 Product Portfolio 15.3.10 Qiagen N.V. 15.3.10.1 Company Overview 15.3.10.2 Product Portfolio 15.3.11 Thermo Fisher Scientific Inc. 15.3.11.1 Company Overview 15.3.11.2 Product Portfolio 15.3.11.3 Financials 15.3.11.4 SWOT Analysis
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（バイオ薬物）の最新刊レポート
IMARC Services Private Limited.社のバイオ薬物分野での最新刊レポート
本レポートと同じKEY WORD（industry）の最新刊レポート
よくあるご質問IMARC Services Private Limited.社はどのような調査会社ですか?インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |
